Pamidronate Disodium — CAS 158749-09-6

Pamidronate Disodium is a bisphosphonate that inhibits osteoclast-mediated bone resorption. It is used in the treatment of hypercalcemia of malignancy, Paget's disease of bone, and osteolytic lesions of multiple myeloma and breast cancer. Mediocon Inc manufactures this API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Treatment of hypercalcemia of malignancy
• Management of Paget's disease of bone
• Prevention and treatment of osteolytic bone lesions in multiple myeloma
• Treatment of osteolytic metastases from breast carcinoma

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support